Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Max Planck reports cysteine-containing compounds as MMP inhibitors

Jan. 12, 1999

Shionogi patents water-soluble inhibitors of human sPLA2

Jan. 12, 1999

Important end-of-year approval by FDA: Celebrex for arthritis

Jan. 4, 1999

New COX-2 inhibitor series patented by Searle

Jan. 4, 1999

Gene transfer of plasmid DNA encoding TGF-beta for suppressing inflammation in arthritis

Dec. 30, 1998

SmithKline Beecham announces setback in RA trials

Dec. 30, 1998

Cytokine production inhibitors for inflammatory disorders in development at Ortho-McNeil

Dec. 30, 1998

Synvisc cleared for marketing in several Pacific Rim countries

Dec. 29, 1998

Phase II trial results for Immune Response's therapeutic RA vaccine published

Dec. 29, 1998

Combination of PGE1 + rolipram or pentoxifylline shows potential for RA

Dec. 28, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...